CLRB
Cellectar Biosciences Inc
NASDAQ: CLRB · HEALTHCARE · BIOTECHNOLOGY
$2.56
-0.02% today
Updated 2026-04-29
Market cap
$11.70M
P/E ratio
—
P/S ratio
348.47x
EPS (TTM)
$-8.35
Dividend yield
—
52W range
$2 – $21
Volume
0.0M
Cellectar Biosciences Inc (CLRB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-170.30%
ROA
-71.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $12584.00 | $-8.29M | 100.00% | -70,961.60% | -65,845.96% |
| 2007 | — | $-19.56M | — | — | — |
| 2008 | $125968.00 | $-16.45M | 100.00% | -13,170.82% | -13,059.99% |
| 2009 | $96314.00 | $-22.27M | 100.00% | -10,620.64% | -23,125.72% |
| 2010 | $33334.00 | $2.10M | 100.00% | -16,351.72% | 6,286.05% |
| 2011 | $-11000.00 | $-7.44M | 100.00% | 63,979.27% | 67,594.75% |
| 2012 | $0.00 | $-8.80M | — | — | — |
| 2013 | $0.00 | $-10.78M | — | — | — |
| 2014 | $0.00 | $-8.11M | — | — | — |
| 2015 | $0.00 | $-5.50M | — | — | — |
| 2016 | $0.00 | $-6.18M | — | — | — |
| 2017 | $0.00 | $-13.56M | — | — | — |
| 2018 | $0.00 | $-13.24M | — | — | — |
| 2019 | $0.00 | $-14.09M | — | — | — |
| 2020 | $0.00 | $-15.09M | — | — | — |
| 2021 | $0.00 | $-23.97M | — | — | — |
| 2022 | $0.00 | $-28.60M | — | — | — |
| 2023 | $0.00 | $-42.77M | — | — | — |
| 2024 | $0.00 | $-44.58M | — | — | — |
| 2025 | $0.00 | $-21.79M | — | — | — |